https://www.diaceutics.com/ https://investors.diaceutics.com/shareholder-information 2024-11-13T11:08:01+00:00 https://investors.diaceutics.com/investor-relations/analyst-research 2025-08-04T12:37:22+00:00 https://investors.diaceutics.com/corporate-governance 2025-05-21T15:42:24+00:00 https://investors.diaceutics.com/significant-shareholders 2025-12-10T12:06:55+00:00 https://investors.diaceutics.com/regulatory-news-service-feed 2026-04-01T12:05:44+00:00 https://investors.diaceutics.com/investors-share-price-information 2023-04-20T11:24:49+00:00 https://investors.diaceutics.com/documents-sent-to-shareholders 2025-05-21T15:15:07+00:00 https://investors.diaceutics.com/advisers 2026-01-29T15:29:59+00:00 https://investors.diaceutics.com/about-diaceutics 2023-04-24T16:33:47+00:00 https://investors.diaceutics.com/board-of-directors 2025-12-18T09:22:48+00:00 https://investors.diaceutics.com/aim-rule-26 2026-03-03T10:53:38+00:00 https://investors.diaceutics.com/esg 2025-08-05T11:09:58+00:00 https://investors.diaceutics.com/investor-contacts 2024-05-23T12:39:21+00:00 https://investors.diaceutics.com/below-investor-artivles 2025-05-21T12:50:09+00:00 https://investors.diaceutics.com/company-profile 2025-05-21T12:43:14+00:00 https://investors.diaceutics.com/why-invest 2026-01-29T14:32:27+00:00 https://investors.diaceutics.com/investor-overview 2026-04-02T23:00:43+00:00 https://investors.diaceutics.com/articles/interim-report-june-2022 2023-04-18T16:52:42+00:00 https://investors.diaceutics.com/articles/diaceutics-plc-h1-2022-results-presentation-slide-deck 2022-10-13T14:30:06+00:00 https://investors.diaceutics.com/articles/diaceutics-corporate-overview-presentation-december-2025 2025-12-09T17:51:10+00:00 https://investors.diaceutics.com/articles/annual-report-2022 2025-01-07T12:25:37+00:00 https://investors.diaceutics.com/articles/diaceutics-is-pleased-to-announce-that-the-group-s-revenue-for-year-end-is-ahead-of-revised-market-expectations 2022-10-10T12:14:33+00:00 https://investors.diaceutics.com/articles/new-vice-president-of-finance-appointment 2021-03-23T11:26:10+00:00 https://investors.diaceutics.com/articles/final-results 2021-03-23T11:26:24+00:00 https://investors.diaceutics.com/articles/diaceutics-plc-annual-report-2023 2024-05-28T22:43:53+00:00 https://investors.diaceutics.com/articles/issue-of-share-options-pdmr-shareholdings 2021-04-07T10:23:16+00:00 https://investors.diaceutics.com/articles/notice-of-capital-markets-day 2021-06-07T09:27:10+00:00 https://investors.diaceutics.com/articles/annual-report-2024 2025-12-15T10:28:47+00:00 https://investors.diaceutics.com/articles/transfer-of-shares-and-director-pdmr-shareholding 2021-04-07T10:25:55+00:00 https://investors.diaceutics.com/articles/diaceutics-announces-the-appointment-of-deborah-davis-as-non-executive-chair 2021-03-23T11:27:09+00:00 https://investors.diaceutics.com/articles/diaceutics-announces-the-resignation-of-julie-goonewardene-as-non-executive-chair 2021-03-23T11:27:10+00:00 https://investors.diaceutics.com/articles/new-vice-president-of-operations-within-the-asia-pacific-region 2021-04-12T08:05:51+00:00 https://investors.diaceutics.com/articles/2020-annual-report 2023-04-18T16:54:18+00:00 https://investors.diaceutics.com/articles/diaceutics-plc-aim-dxrx-the-diagnostic-commercialisation-company-announces-its-unaudited-interim-results-for-the-six-months-ended-30-june-2021 2021-11-10T15:39:32+00:00 https://investors.diaceutics.com/articles/diaceutics-plc-financial-year-2021-results-presentation 2022-03-23T10:21:16+00:00 https://investors.diaceutics.com/articles/2021-annual-report 2022-04-28T13:53:35+00:00 https://investors.diaceutics.com/articles/dxrx-platform-contract-win 2021-09-13T12:42:41+00:00 https://investors.diaceutics.com/articles/interim-report-june-2021 2023-04-18T16:53:51+00:00 https://investors.diaceutics.com/articles/virtual-capital-markets-event-presentation 2024-06-12T14:00:14+00:00 https://investors.diaceutics.com/articles/h1-2024-results-presentation 2024-09-18T09:19:28+00:00 https://investors.diaceutics.com/articles/pdmr-shareholding-share-incentive-plan-and-total-voting-rights 2025-08-05T10:28:10+00:00 https://investors.diaceutics.com/articles/diaceutics-releases-interim-results-for-period-ended-30-june-2022 2023-01-10T15:34:04+00:00 https://investors.diaceutics.com/articles/trading-statement-for-year-ended-31-dec-22 2023-04-19T14:02:48+00:00 https://investors.diaceutics.com/articles/capital-markets-day-video-presentation 2023-04-18T16:54:02+00:00 https://investors.diaceutics.com/articles/trading-update-and-strategy-acceleration 2023-02-14T14:14:20+00:00 https://investors.diaceutics.com/articles/commercial-launch-of-dxrx-the-diagnostic-network 2023-04-18T16:54:36+00:00 https://investors.diaceutics.com/articles/2019-annual-report 2023-04-18T16:54:45+00:00 https://investors.diaceutics.com/articles/interim-report-june-2019 2023-04-18T16:54:57+00:00 https://investors.diaceutics.com/articles/interim-report-june-2020 2023-04-18T16:55:08+00:00 https://investors.diaceutics.com/articles/diaceutics-plc-financial-year-2022-results-outlook 2023-04-19T10:02:47+00:00 https://investors.diaceutics.com/articles/diaceutics-releases-half-year-results-for-period-ended-30-june-2023 2023-07-26T09:20:56+00:00 https://investors.diaceutics.com/articles/notice-of-interim-results-upcoming-investor-and-analyst-presentations 2024-02-06T16:18:47+00:00 https://investors.diaceutics.com/articles/register-your-interest-diaceutics-pmx-capital-markets-webinar 2024-11-12T09:24:55+00:00